Literature DB >> 1558265

Community participation in malaria surveillance and treatment. II. Evaluation of the volunteer collaborator Network of Guatemala.

T K Ruebush1, R Zeissig, R E Klein, H A Godoy.   

Abstract

To evaluate the effectiveness of the Volunteer Collaborator Network (VCN) of Latin America as a community-based malaria case detection and treatment system, we conducted a study of the VCN of Guatemala. Volunteer Collaborators took 72.6% of all blood smears and identified 81.3% of all malaria cases reported by the Guatemalan National Malaria Service. The average volunteer treated 5.8 patients per month (range 0-32.8). In contrast, passive case detection (PCD) posts in government hospitals and health centers treated an average of 12.5 patients per month (range 0.5-91.4). The slide positivity rate of blood smears taken by Volunteer Collaborators was 16.2% compared with 9.7% for PCD posts in health centers and 10.3% for malaria workers during active case detection. The average delay between the date a blood smear was taken and examined ranged from 18.1 days on the Pacific coastal plain to 26.3 days in the less accessible northern region of the country. An additional 14.5 to 47.6 days elapsed before the radical treatments were initiated in these two regions. Seventy percent of the patients completed their radical treatments. In a survey conducted on the Pacific coastal plain of Guatemala, of 1,021 patients with chills and/or fever who believed they had malaria, 20.0% had visited a Volunteer Collaborator and 4.9% were treated at a government health center. Thus, the PCD network detected only 25% of all patients with symptoms suggestive of malaria. Most of the remaining patients treated themselves with antimalarial medications purchased in stores and pharmacies, but less than 15% of these patients used adequate courses of therapy. Furthermore, the rate of detection of symptomatic patients with malaria varied considerably from one community to another. Thus, data from the VCN are probably most useful when groups of communities or geographic areas are stratified for malaria control activities because at this level, variations between individual Volunteer Collaborator posts will be minimized. In spite of these problems, the VCN remains an excellent source of epidemiologic data for malaria control programs and the most practical means available for providing timely, appropriate antimalarial therapy to febrile patients in rural areas.

Entities:  

Mesh:

Year:  1992        PMID: 1558265     DOI: 10.4269/ajtmh.1992.46.261

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

Review 1.  A framework for assessing the feasibility of malaria elimination.

Authors:  Bruno Moonen; Justin M Cohen; Andy J Tatem; Jessica Cohen; Simon I Hay; Oliver Sabot; David L Smith
Journal:  Malar J       Date:  2010-11-11       Impact factor: 2.979

Review 2.  The architecture and effect of participation: a systematic review of community participation for communicable disease control and elimination. Implications for malaria elimination.

Authors:  Jo-An Atkinson; Andrew Vallely; Lisa Fitzgerald; Maxine Whittaker; Marcel Tanner
Journal:  Malar J       Date:  2011-08-04       Impact factor: 2.979

Review 3.  Towards eliminating malaria in high endemic countries: the roles of community health workers and related cadres and their challenges in integrated community case management for malaria: a systematic review.

Authors:  Bruno F Sunguya; Linda B Mlunde; Rakesh Ayer; Masamine Jimba
Journal:  Malar J       Date:  2017-01-03       Impact factor: 2.979

4.  Made in Europe: will artemisinin resistance emerge in French Guiana?

Authors:  Mathieu Nacher; Philippe J Guérin; Magalie Demar-Pierre; Félix Djossou; François Nosten; Bernard Carme
Journal:  Malar J       Date:  2013-05-04       Impact factor: 2.979

5.  Impact of community-based presumptive chloroquine treatment of fever cases on malaria morbidity and mortality in a tribal area in Orissa State, India.

Authors:  Lalit K Das; Purushothaman Jambulingam; Candasamy Sadanandane
Journal:  Malar J       Date:  2008-05-05       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.